The global biosimilar market is expected to reach USD 36 billion by 2022. However, only some countries are favorable for biosimilars due to reasons ranging from poor accessibility to unconducive regulatory environments. This infographic takes a closer look at the market favorability for biosimilars across developed, BRIC, and MIST countries, number of biosimilars in the pipeline, top players in the biologic market, country-wise share of total biologic sales, and more.
Enter your details to download the infographic.
For a complete report of the biosimilar market, including the industry trends, patent landscape, competitive analysis and market outlook, write to firstname.lastname@example.org.